Skip to main content

Peer Review reports

From: Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81–8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare setting

Original Submission
10 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
1 Feb 2022 Reviewed Reviewer Report
30 Mar 2022 Reviewed Reviewer Report
13 May 2022 Author responded Author comments - Jean Malacan
Resubmission - Version 5
13 May 2022 Submitted Manuscript version 5
15 May 2022 Author responded Author comments - Jean Malacan
Resubmission - Version 6
15 May 2022 Submitted Manuscript version 6
18 May 2022 Author responded Author comments - Jean Malacan
Resubmission - Version 7
18 May 2022 Submitted Manuscript version 7
23 May 2022 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
23 May 2022 Editorially accepted
5 Aug 2022 Article published 10.1186/s12874-022-01659-w

You can find further information about peer review here.

Back to article page